Healthcare & Life Sciences
GENEPRED
Francegenepredict.fr
GENEPRED is a Healthcare & Life Sciences startup based in France, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About GENEPRED
GENEPRED is a startup based in France. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
GENEPRED provides Melapred Access, a clinico-genetic test that calculates an individual melanoma risk score by integrating genetic markers and clinical factors to enable personalized melanoma prevention and monitoring.
Explore GENEPRED's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.